Related Experiment Video
Updated: Jul 9, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Role of vaccine therapy in cancer: biology and practice
J Schlom1, J L Gulley, P M Arlen
1Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. js141c@nih.gov
Abstract:
Vaccines constitute a potential new therapeutic approach for a range of human cancers. Unlike other therapeutics, vaccines initiate a dynamic process in the host immune system that can be exploited with subsequent therapies. Indeed, recent preclinical and clinical studies with cancer vaccines have provided evidence that this unique therapeutic modality should lead to consideration of new paradigms in both clinical trial design and endpoints and in combination therapies. The present article reviews and sets out a rationale for these new paradigms, with a focus on prostate cancer.
Insights
Cancer vaccines offer a novel therapeutic strategy by engaging the host immune system. This approach necessitates new clinical trial designs and combination therapies, particularly for prostate cancer treatment.
Area of Science:
- Oncology
- Immunotherapy
- Cancer Therapeutics
Background:
- Cancer vaccines represent a promising therapeutic avenue for various human cancers.
- Unlike conventional treatments, vaccines stimulate a dynamic host immune response.
- This immune stimulation can be leveraged for enhanced therapeutic outcomes.
Purpose of the Study:
- To review the current landscape of cancer vaccines.
- To propose new paradigms for clinical trial design and combination therapies.
- To focus on the application of these paradigms in prostate cancer.
Main Methods:
- Review of preclinical and clinical studies on cancer vaccines.
- Analysis of the immunological mechanisms of cancer vaccines.
- Exploration of potential combination strategies with other cancer therapies.
Main Results:
- Cancer vaccines initiate a unique host immune response.
- Evidence suggests a need for revised clinical trial designs and endpoints.
- Combination therapies involving cancer vaccines show potential.
Conclusions:
- Cancer vaccines offer a distinct therapeutic modality.
- New paradigms are required for effective clinical implementation.
- Prostate cancer serves as a key focus for exploring these new approaches.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

